CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (accRCC): Results from cohort A of KEYNOTE-427.
Authors
Boris Yakovlevich Alekseev
Cezary Szczylik
+18Â more
Charles Schloss
David F. McDermott
Frede Donskov
Frederic Pouliot
Jae-Lyun Lee
Jahangeer Malik
James M. G. Larkin
Michael B. Atkins
Pawel J. Wiechno
Piotr Tomczak
Poul F. Geertsen
Rodolfo F. Perini
Rustem Airatovich Gafanov
Sang Joon Shin
Scott S. Tykodi
Teresa Alonso Gordoa
Vsevolod Borisovich Matveev
Wenting Li
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 25/10/2020